(Q37733892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

review article

1 reference

title

Combination drug-diet therapies for dyslipidemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Scott V. Harding

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Peter Jones

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Christopher P F Marinangeli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

19 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

220-227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20403577%20AND%20SRC:MED&resulttype=core&format=json

Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Guar gum consumption increases hepatic nuclear SREBP2 and LDL receptor expression in pigs fed an atherogenic diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Nicotinic acid: a new look at an old drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Newer, lower, better? Lipid drugs and cardiovascular disease--the continuing story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effects of cerivastatin withdrawal on statin persistence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Reviewing your investment strategy: where does diet fit in your personal portfolio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Serum Lipid and Antioxidant Responses in Hypercholesterolemic Men and Women Receiving Plant Sterol Esters Vary by Apolipoprotein E Genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Identification of genetic variants associated with response to statin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Impact of apolipoprotein A5 variants on statin treatment efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Association of CYP7A1 -278A>C polymorphism and the response of plasma triglyceride after dietary intervention in dyslipidemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Clinical efficacy and safety of statins in managing cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Plant sterol consumption frequency affects plasma lipid levels and cholesterol kinetics in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

The effects of statins and sitosterols: benefit or not?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effect of guar gum on blood lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effect of combining psyllium fiber with simvastatin in lowering cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Colesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

The 'forgotten' bile acid sequestrants: is now a good time to remember?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Lipid-lowering effects of colesevelam HCl in combination with ezetimibe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

n-3 polyunsaturated fatty acids and coronary thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Flushing profile of extended-release niacin/laropiprant at initiation of therapy in Asian lipid clinic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Ezetimibe: cholesterol lowering and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Effect of high plant sterol-enriched diet and cholesterol absorption inhibitor, SCH 58235, on plant sterol absorption and plasma concentrations in hypercholesterolemic wild-type Kyoto rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

The polypill and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Drug combinations and all cause mortality in heart disease: dosages and types of ACE inhibitors need to be known

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

Low-density lipoprotein in the setting of congestive heart failure: is lower really better?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005

After ENHANCE: is more LDL cholesterol lowering even better?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.005